Metformin Hydrochloride Sandoz

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Sandoz, is a biguanide presented as an oral tablet for oral use. It is used to improve blood glucose control in adults with type 2 diabetes mellitus. GNH USA supplies Metformin Hydrochloride Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is indicated for conditions affecting glucose metabolism and insulin sensitivity. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels to achieve glycaemic targets. - Prediabetes: helps delay progression to overt diabetes by improving insulin sensitivity. - Polycystic ovary syndrome: reduces insulin resistance and may improve menstrual regularity.

Metformin Hydrochloride may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Diarrhoea: loose stools, usually early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic dysfunction: signs of liver injury. - Significant hypoglycaemia: when combined with other glucose‑lowering agents. - Vitamin B12 deficiency: may develop with long‑term use. - Acute pancreatitis: rare inflammatory condition of the pancreas.

Metformin Hydrochloride requires careful patient assessment and monitoring. - Renal function: evaluate creatinine clearance before initiation and periodically thereafter. - Hepatic function: avoid use in patients with severe liver disease. - Risk of lactic acidosis: contraindicated in severe renal impairment or acute metabolic acidosis. - Pregnancy: use only if potential benefit justifies potential risk to the fetus. - Alcohol consumption: limit intake to reduce risk of acidosis. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate renal dysfunction and lactic acidosis. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemic symptoms. - Diuretics: can affect renal clearance of metformin.